Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients
NCT04269369
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Stomach Tumor
Anal Tumor
Pancreas Cancer
Esophageal Cancer
Interventions
DRUG:
5-Fluorouracil
Sponsor
Jessa Hospital